This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) and is used in the treatment of seizures.
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
The composition of ORAAL is protected by a granted patent in India until November 2033
Subscribe To Our Newsletter & Stay Updated
